Clinical Trials in Zhujiang, China
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Advanced Solid TumorRefractory Hodgkin Lymphoma
FBD Biologics Limited50 enrolled6 locationsNCT06487624
Recruiting
Phase 3
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
Chronic Myelomonocytic Leukemia
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.170 enrolled43 locationsNCT06647862